Terazosin Hydrochloride 98%
70024-40-7
Pharmaceutical Grade
98%
Any China Port
10kg/Cardboard Drum
2020-01-27
Nicotinamide,Paracetamol,R-Tetrahydropapaverine N-acetyl-L-leucinate R-,Clopidogrel Bisulfate,Cisatracurium Besilate,Dopamine Hydrochloride
-
Product Description
-
Seller Information
-
DescriptionBasic Info
-
Product Name:
Terazosin monohydrochloride dihydrate
Other Name:Methanone,[4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl](tetrahydro-2-furanyl)-,hydrochloride,hydrate (1:1:2);Piperazine,1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-,monohydrochloride,dihydrate;Terazosin monohydrochloride dihydrate;Terazosin hydrochloride dihydrate
CAS No.:70024-40-7
Molecular Formula:C19H25N5O4.ClH.2H2O
InChIKeys:InChIKey=NZMOFYDMGFQZLS-UHFFFAOYSA-N
Molecular Weight:459.92
Exact Mass:459.188446
EC Number:1533716-785-6
HScode:2934990002
Categories:
Characteristics-
PSA:
105
Melting Point:271-274 °C
Toxicity:LD50 in male, female rats (mg/kg): 277, 293 i.v. (Fort)
Hazard IdentificationClassification of the substance or mixture
Eye irritation, Category 2
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Warning
Hazard statement(s) H319 Causes serious eye irritation
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
Response P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
Storage none
Disposal none
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Nicotinamide,Paracetamol,R-Tetrahydropapaverine N-acetyl-L-leucinate R-,Clopidogrel Bisulfate,Cisatracurium Besilate,Dopamine Hydrochloride
-
Location:
Chengguan Town, Wuqing District, Tianjin Province, China
-
Payment Terms:
TT against copy of documents,O/A
-
Average lead Time:
10
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
101-200
-
Year of Establishment:
2004
-
Certifications:
China Great Wall (Tianjin) Quality Assurance Center Environment Management System Certification,HALAL,KOSHER,GMP,GMP,GMP,GMP
Tianjin Zhongrui Pharmaceutical co., Ltd. is a professional productive enterprise which dedicates to manufacture pharmaceutical ingredients and intermediates, and established in 2004 with total registered capital of CNY 26 million. The legal representative is Liu Changsuo and chief founders are natural persons from Beijing. Company’s main products include Niacin, Niacinamide , Inositol Nicotinate, Terazosin Hcl, Amifostine, Strontium Renalate, Cisatracurium Besilate, Fasudil Hcl, Clopidogrel hydrogen sulfate, Dopamine Hcl, Febuxostat, etc.
Tianjin Zhongrui serves as an integrated pharmaceutical manufacturer, owning advanced production equipments, "GMP" workshops, and various sophisticated testing instruments. Most company leadership team members are professional and technical with rich experience in pharmaceutical, gaining college degree or above education. The site covers a total area of 21000㎡, of which production workshops 1656 ㎡, QC laboratory 360㎡. Production lines of all raw materials are equipped with special equipments and independent air conditioning system. Our quality control capability is qualified to the production scale. All products pass the GMP certification. Our facility conditions conform to the requirements of the technology, production safety, environmental protection. Internal research institute is equipped with advanced R&D equipments and pilot plant.
Tianijn Zhongrui relies on strong technical force, high-quality work team, perfect quality assurance system to build ourselves as a high-tech enterprise. Therefor the company has achieved rapidly development.
In 2009, Tianjin Zhongrui was identified as high-tech enterprises, and passed the reexamination in 2012. New production technology of Nicotinamide was incorporated into science and technology innovation projects of Tianjin Science and Technology Commission. Strontium Ranelate gets supported by “technology personnel service enterprise action” project of Ministry of Science. The company spent more than CNY3 million on R&D in 2012.
In 2009, in order to introduce the advanced production technology of new drugs and pursue the better development, Tianjin Zhongrui cooperated with a technology-based private institute from Beijing, which is specialized in new drug research and development. This institute invested six new drug’s research achievements and CNY6 million to Tianjin Zhongrui, which injected a huge fresh vitality of science and technology.
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product